Molecular Templates

Focused on the development of proprietary targeted biologic therapeutics

Molecular Templates is focused on the discovery and development of targeted biologic therapeutics. The company’s proprietary drug platform technology, known as engineered toxin bodies (ETBs), leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Status
NASDAQ: MTEM
Year of Investment
2020
Strategy
Life Sciences
Location
Austin, Texas